Chargement de la fiche…
Chargement de la fiche…
Praticien hospitalier
Photo : Cereol89 , Velvet, CC BY-SA 4.0, Wikimedia Commons
Dans les médias
Vous êtes Dr Jean-Guillaume Letarouilly ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dr Jean-Guillaume Letarouilly est rhumatologue à Lille (59037). Il consulte à HÔPITAL SALENGRO CHU LILLE, CITE HOSPITALIERE — Rue EMILE LAINE, 59037 Lille.
Consulter
HÔPITAL SALENGRO CHU LILLE
CITE HOSPITALIERE — Rue EMILE LAINE, 59037 Lille
Dr Jean-Guillaume Letarouilly, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Hospitalier
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'études spécialisées
DE Docteur en médecine — Capacité / certificat d'études spéciales
Les plus citées
2019Genomics68 citations
New insights into the epigenetics of osteoporosis
2022Joint bone spine52 citations
2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis
2022Nutrients44 citations
Efficacy of Probiotics in Rheumatoid Arthritis and Spondyloarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Contenus publics où le nom du praticien apparaît (YouTube, Google Actualités).
En bref
Dr Jean-Guillaume Letarouilly consulte à HÔPITAL SALENGRO CHU LILLE, CITE HOSPITALIERE — Rue EMILE LAINE, 59037 Lille. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 03 20 44 59 62 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Lille, j'accompagne…
Exemple : vous choisissez vos propres domaines.
2026The Lancet. RheumatologyPubMed
Innovative therapies in rheumatoid arthritis: CAR T cells and bispecific antibodies
2026RMD openPubMed
Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort
2022Journal of clinical medicinePubMed
Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk Warnings
2022NutrientsPubMed
Efficacy of Probiotics in Rheumatoid Arthritis and Spondyloarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2021Expert opinion on drug safetyPubMed
Factors affecting persistence with biologic treatments in patients with rheumatoid arthritis: a systematic literature review
2021Therapeutic advances in musculoskeletal diseasePubMed
Body composition in patients with rheumatoid arthritis: a narrative literature review
2020NutrientsPubMed
Efficacy of Spice Supplementation in Rheumatoid Arthritis: A Systematic Literature Review
2020Journal of clinical medicinePubMed
Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network
2026The Journal of rheumatologyPubMed
GRAPPA Research Projects: Development of Criteria for Axial Psoriatic Arthritis and Definitions of Complex-to-Manage and Treatment-Refractory Psoriatic Arthritis
2026Best practice & research. Clinical rheumatologyPubMed
Difficult to treat disease in psoriatic arthritis- is it different from axial spondyloarthritis?
2026Therapeutic advances in musculoskeletal diseasePubMed
The protocol for a patient-driven online prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis among people living with psoriasis: the HIPPOCRATES Prospective Observational Study
2025Rheumatology (Oxford, England)PubMed
Deciphering difficult-to-treat psoriatic arthritis: insights from an international survey of patients with psoriatic arthritis
2023Seminars in arthritis and rheumatismPubMed
Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis
2022Joint bone spinePubMed
Erratum to "2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis" [Joint Bone Spine 2022;89:105344]
2022Joint bone spinePubMed
2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis
2021Rheumatology (Oxford, England)PubMed
Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison
2026Joint bone spinePubMed
Answer to Elbaz et al
2026Joint bone spinePubMed
Skin cancer risk in patients with non-dermatologic immune-mediated inflammatory diseases
2023Rheumatology (Oxford, England)PubMed
Therapeutic consequences in patients with both inflammatory rheumatic diseases and multiple sclerosis
2022Journal of patient experiencePubMed
Self-reported Impact of the Early 2020 COVID-19 Crisis on the Healthcare Pathway During and After Lockdown in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Practical Survey
2021PloS onePubMed
Adipocyte-induced transdifferentiation of osteoblasts and its potential role in age-related bone loss
2022Joint bone spinePubMed
Treatment persistence of tumour necrosis factors and IL-17 inhibitors in axial spondyloarthritis: A multi-center comparative analysis
2022Rheumatology (Oxford, England)PubMed
New-onset inflammatory bowel diseases among IL-17 inhibitor-treated patients: results from the case-control MISSIL study
2021Rheumatology (Oxford, England)PubMed
Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison
2025La Revue de medecine internePubMed
Safety profile of JAK inhibitors in inflammatory or autoimmune diseases
2022Journal of clinical medicinePubMed
Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk Warnings
2022Frontiers in endocrinologyPubMed
Stimulatory Effect of Tofacitinib on Bone Marrow Adipocytes Differentiation
2026Arthritis & rheumatology (Hoboken, N.J.)PubMed
Exploring the Potential of Cluster Analysis in Identifying Disease Phenotypes in Calcium Pyrophosphate Deposition: Moving From Intuition to Insight
2024Rheumatology (Oxford, England)PubMed
Retention, safety and efficacy of off-label conventional treatments and biologics for chronic calcium pyrophosphate crystal inflammatory arthritis
2025Joint bone spinePubMed
French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseases
2022Joint bone spinePubMed
Dietary recommendations of the French Society for Rheumatology for patients with chronic inflammatory rheumatic diseases
2022Arthritis research & therapyPubMed
Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis
2020NutrientsPubMed
Efficacy of Oral Vitamin Supplementation in Inflammatory Rheumatic Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2022Arthritis research & therapyPubMed
Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis
2020NutrientsPubMed
Efficacy of Oral Vitamin Supplementation in Inflammatory Rheumatic Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2026 · Article
Answer to Elbaz et al.
2026 · Article
Exploring the potential of cluster analysis in identifying disease phenotypes in CPPD: Moving from intuition to insight
2026 · Article
Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort
2026 · Article
Preconception, pregnancy and postpartum periods in spondyloarthritis: Unmet needs and challenges from a patients and rheumatologists surveys
2025 · Article
Élaboration par consensus d’experts d’une liste des thématiques d’information du patient à aborder lors de la dispensation d’une thérapie ciblée pour un patient atteint d’un rhumatisme inflammatoire en pharmacie d’officine
2025 · Article
French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseases
2025 · Article
Safety profile of JAK inhibitors in inflammatory or autoimmune diseases.
2025 · Article
Deciphering difficult-to-treat psoriatic arthritis (D2T-PsA): insights from an international survey of patients with psoriatic arthritis.
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.